The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 18,701–18,800 of 31,469
Liu, X., Zhang, Y., Li, Y., Sang, Y., Chai, Y., Zhang, L., & Zhang, H. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01725-y · Cited by 14
Zeng, H., Peng, L., Liu, C., Zhou, Y., Wan, L., Wen, S., Fang, W., Yang, X., Bai, Q., Zeng, J., et al. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.141785 · Cited by 15
Aly, O., Mekky, R. H., Pereira, F., Diab, Y. M., Tammam, M. A., & El‐Demerdash, A. (2024) · Food & Function · doi:10.1039/d4fo04602a · Cited by 13
Yin, J., Zheng, C., Li, Z., Chang, Y., Cao, L., & Qu, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02404-6 · Cited by 13
Chen, H., Chen, S., Liu, D., Liang, Y., Li, H., Bao, Y., Zhu, Z., Dong, K., Li, W., Liang, F., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101884 · Cited by 14
Monem, M. S. A., Adel, A., Abbassi, M., Abdelaziz, D. H., Hassany, M., Raziky, M. E., & Sabry, N. A. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102543 · Cited by 14
Liu, N., Wang, B., Zhang, G., Shen, M., Peng, C., Guo, Z., Zuo, L., Yang, J., Guo, M. A., Wang, M., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2462447 · Cited by 13
Gao, L., Zhang, S., Li, S., Luo, M., Lin, P., Zhao, Z., Zhao, Q., Yang, T., Duan, A., Wang, Y., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02630-x · Cited by 14
Orioli, L., & Thissen, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1554617 · Cited by 17
Teparak, C., Uriyapongson, J., Phoemsapthawee, J., Tunkamnerdthai, O., Aneknan, P., Tong-un, T., Panthongviriyakul, C., Leelayuwat, N., & AlKhatib, A. H. (2025) · Nutrients · doi:10.3390/nu17071098 · Cited by 17
Trinh, B., Rasmussen, S. J., Brøgger-Jensen, M. E., Engelhard, C. A., Lund, A., Tavanez, A. R., Vassilieva, A., Janum, S., Iepsen, U. W., Kiens, B., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102042 · Cited by 17
Antidiabetic activity of 3-hydroxyflavone analogues in high fructose fed insulin resistant rats
Nayak, Y., Venkatachalam, H., Daroji, V. K., Mathew, G., Jayashree, B. S., & Unnikrishnan, M. K. (2014) · Europe PMC (PubMed Central) · doi:10.17877/de290r-6937 · Cited by 13
de Luis, D. A., Sagrado, M. G., Aller, R., Conde, R., Izaola, O., de la Fuente, B., & Primo, D. (2011) · PubMed · doi:10.1590/s0212-16112011000200012 · Cited by 13
Chen, Y., Tzeng, C., Cheng, Y., et al. (2015) · Phytotherapy Research · doi:10.1002/ptr.5314 · Cited by 13
Aziz, M., Sidelmann, J. J., Wissing, M. L., Faber, J. O., & Skouby, S. O. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1032930 · Cited by 13
Association ofPPAR‐γ2andβ3‐ARPolymorphisms With Postmenopausal Hypertension
Grygiel‐Górniak, B., Kaczmarek, E., Mosor, M., Przysławski, J., & Nowak, J. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12537 · Cited by 13
Tenor, D. P., Berenguer, J., Jiménez‐Sousa, M. Á., García–Álvarez, M., Aldámiz‐Echevarría, T., Carrero, A., Vázquez‐Morón, S., García‐Broncano, P., Díez, C., Tejerina, F., et al. (2014) · BMC Medicine · doi:10.1186/preaccept-6608070031382979 · Cited by 13
El-Hafez, H. A. A., Elrakhawy, M. M., El-Baiomy, A. A., & El-Eshmawy, M. M. (2014) · ISRN Obesity · doi:10.1155/2014/545804 · Cited by 13
Non-alcoholic fatty liver disease in patients with migraine
Çelikbilek, A., Çelikbilek, M., Okur, A., et al. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1798-1 · Cited by 13
Winzer, B., Paratz, J. D., Whitehead, J. P., Whiteman, D. C., & Reeves, M. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117922 · Cited by 14
Insulin Resistance and Risk for Incident Heart Failure ∗
McGuire, D. K., & Gore, M. O. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.11.001 · Cited by 13
Wu, C., Chang, L.-C., Lin, Y., Hung, Y.-J., Pei, D., & Chen, J.-S. (2015) · Disease Markers · doi:10.1155/2015/548101 · Cited by 13
Ezenwaka, C. E., Nwagbara, E., Seales, D., et al. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802676343 · Cited by 13
Is There Evidence of Separate Inflammatory or Metabolic Forms of Preeclampsia?
Founds, S. A., Catov, J. M., Gallaher, M. J., Harger, G. F., Marković, N., & Roberts, J. M. (2010) · Hypertension in Pregnancy · doi:10.3109/10641950903322907 · Cited by 13
Which metabolic syndrome criteria best predict the presence of non-alcoholic fatty liver disease?
Seo, H. I., Cho, Y. K., Lee, W., Rhee, E., Sung, K., Kim, B. S., Son, B. H., Shin, J. H., Joo, K. J., Hong, H. P., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.08.013 · Cited by 13
The design of the liraglutide clinical trial programme
Nauck, M. A. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01573.x · Cited by 13
Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitus
Xia, W., Shao, Y., Wang, Y., et al. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03347101 · Cited by 13
Tan, S., Vollmar, N., Benson, S., Sowa, J., Bechmann, L. P., Gerken, G., Führer, D., & Canbay, A. E. (2015) · International Journal of Endocrinology · doi:10.1155/2015/254169 · Cited by 12
Modifications of the homeostasis model assessment of insulin resistance index with age
Soriguer, F., Colomo, N., Valdés, S., Goday, A., Rubio‐Martín, E., Esteva, I., Castaño, L. A., de Adana, M. S. R., Morcillo, S., CALLE, A. L., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-013-0523-5 · Cited by 16
de Luis, D. A., Aller, R., Izaola, O., Gómez, J. J. L., Gomez, E., Torres, B., & Díaz-Soto, G. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0117-2 · Cited by 13
Hitsumoto, T., & Shirai, K. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s80907 · Cited by 13
Lancha, A., López-Garrido, S., Rodrı́guez, A., Catalán, V., Ramírez, B., Valentí, V., Moncada, R., Silva, C., Gil, M. J., Salvador, J., et al. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.12.003 · Cited by 13
Predictors of insulin resistance in the obese with metabolic syndrome
Manu, P., Tsang, J. C., Napolitano, B. A., LESSER, M. L., & Correll, C. U. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.05.015 · Cited by 13
Han, T., Wang, X., Cui, Y.-P., et al. (2007) · PEDIATRICS · doi:10.1542/peds.2006-3297 · Cited by 13
Ferrante, E., Malavazos, A. E., Giavoli, C., Ermetici, F., Coman, C., Bergamaschi, S., Profka, E., Briganti, S., Ronchi, C. L., Passeri, E., et al. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.09.001 · Cited by 13
Jordy, A. B., Serup, A. K., Karstoft, K., Pilegaard, H., Kiens, B., & Jeppesen, J. F. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00124.2014 · Cited by 13
Hong, H.-R., Ha, C., Kong, J., Lee, S., Song, M.-G., & Kang, H. (2014) · Physical Activity and Nutrition · doi:10.5717/jenb.2014.18.4.361 · Cited by 13
Adiponectin: Are Measurements Clinically Useful in Pregnancy?
Mouzon, S. H., & Catalano, P. M. (2013) · Diabetes Care · doi:10.2337/dc12-2532 · Cited by 13
Helaly, G. F., Hussein, N., Refai, W., & Ibrahim, M. (2011) · Translational research · doi:10.1016/j.trsl.2011.04.005 · Cited by 13
Tyler, B. Z. M. B. (2013) · Clinical Pharmacology & Biopharmaceutics · doi:10.4172/2167-065x.1000110 · Cited by 13
Finucane, F. M., Horton, J., Purslow, L. R., Savage, D. B., Brage, S., Besson, H., Horton, K., Rolfe, E. D. L., Sleigh, A., Sharp, S. J., et al. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-15 · Cited by 13
Tong, J., D’Alessio, D. A., Ramisch, J., Davis, H. W., Stambrook, E., Tschöp, M. H., & Bidlingmaier, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2012 · Cited by 13
Jelínek, D., Castillo, J., Richardson, L. M., et al. (2012) · Journal of Nutrition · doi:10.3945/jn.112.162818 · Cited by 13
Sanchez, O. A., Duprez, D. A., Bahrami, H., et al. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.04.005 · Cited by 13
Praveen, E. P., Kulshreshtha, B., Khurana, M. L., Sahoo, J., Gupta, N., Kumar, G., Ammini, A. C., & Knadgawat, R. (2011) · HORMONES · doi:10.14310/horm.2002.1293 · Cited by 13
Hyötyläinen, T., Mattila, I. M., Wiedmer, S. Κ., Koivuniemi, A., Taskinen, M., Yki‐Järvinen, H., & Orešič, M. (2012) · Molecular BioSystems · doi:10.1039/c2mb25115a · Cited by 13
Backeström, A., Eriksson, S., Nilsson, L., Olsson, T., & Rolandsson, O. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0014-7 · Cited by 13
Iwasa, M., Hara, N., Miyachi, H., et al. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01119.x · Cited by 13
Ma, H., Lin, H., Hu, Y., Li, X., He, W., Jin, X., Gao, J., Zhao, N., & Gao, X. (2014) · Angiology · doi:10.1177/0003319713520462 · Cited by 13
de Siqueira, F. R., Furukawa, L. N. S., Oliveira, I. B., & Heimann, J. C. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.11.013 · Cited by 13
Xiao, W.-Y., Ning, N., Tan, M., Jiang, X.-S., Zhou, L., Liu, L., Yi, D., & Wei, P. Y. (2016) · Hypertension Research · doi:10.1038/hr.2015.155 · Cited by 13
Bal, Y., Adaş, M., & Helvacı, A. (2010) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657354 · Cited by 13
Kumar, A. N. (2019) · Figshare · doi:10.6084/m9.figshare.8113250 · Cited by 13
de BARROS, F., Setúbal, S., Martinho, J. M., Leite, N. C., Guaraná, T., Monteiro, A. B. S., & Villela‐Nogueira, C. A. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2054-y · Cited by 13
Mellor, D. D., & Naumovski, N. (2016) · International Journal of Food Science & Technology · doi:10.1111/ijfs.13075 · Cited by 13
Snehalatha, C., Jagannathan, R., Nanditha, A., Shetty, A. S., Sevick, M. A., Bergman, M., Johnston, D. G., & Ramachandran, A. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2799 · Cited by 13
Wright, C. S., Craddock, A., Weinheimer-Haus, E. M., Lim, E., Conley, T. B., Janle, E. M., & Campbell, W. W. (2016) · Endocrine Research · doi:10.3109/07435800.2015.1094083 · Cited by 13
Kong, X., Xing, X., Hong, J., Zhang, X., & Yang, W. (2016) · Clinical Genetics · doi:10.1111/cge.12817 · Cited by 13
Lai, S., Petramala, L., Mastroluca, D., Petraglia, E., Gaeta, A. D., Indino, E. L., Panebianco, V., Ciccariello, M., Shahabadi, H., Galani, A., et al. (2016) · Medicine · doi:10.1097/md.0000000000004175 · Cited by 13
Vogt, S., Baumert, J., Peters, A., et al. (2016) · Public Health Nutrition · doi:10.1017/s1368980016001762 · Cited by 13
Impact of age on plasma vaspin concentration in a group of normal Chinese people
Xu, X., Wen, J., Lu, Y. W., et al. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0533-6 · Cited by 13
Effects of Liraglutide and Vitamin E in Fructose-Induced Metabolic Syndrome in Rats
Geddawy, A., Hussian, M., Kamel, M. Y., Kamal, R., & Ibrahim, M. A. (2016) · Pharmacology · doi:10.1159/000449429 · Cited by 13
Gong, L., Li, R., Ren, W., Wang, Z., Wang, Z., Yang, M., & Zhang, S. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.2.264 · Cited by 13
de BARROS, F., Setúbal, S., Martinho, J. M., et al. (2016) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-6720201600040011 · Cited by 13
Garmendia, M. L., Zamudio, C., Araya, M., & Kain, J. (2017) · Nutrition · doi:10.1016/j.nut.2017.01.003 · Cited by 13
Sedky, A. A., Serafy, O. M. H. E., Hassan, O. A., et al. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0263 · Cited by 13
The impact of obesity on hyperandrogenemia in Korean girls
Kang, M. J., Yang, S., & Hwang, I. T. (2016) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2016.21.4.219 · Cited by 13
Straznicky, N. E., Grima, M. T., Sari, C. I., Eikelis, N., Nestel, P. J., Dixon, J. B., Lambert, G. W., Schlaich, M. P., Phillips, S. E., & Lambert, É. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00203 · Cited by 13
Lee, C. C., Young, K. A., Norris, J. M., Rotter, J. I., Liu, Y., Lorenzo, C., Wagenknecht, L. E., Cole, D. E. C., Haffner, S. M., Chen, Y. I., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00039 · Cited by 13
Pardina, E., Ferrer, R., Rossell, J., Ricart-Jané, D., Méndez‐Lara, K. A., Baena‐Fustegueras, J. A., Lecube, A., Julve, J., & Peinado‐Onsurbe, J. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.115 · Cited by 13
Ibrahim, K. G., Chivandi, E., Mojiminiyi, F. B. O., & Erlwanger, K. H. (2017) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s204017441700040x · Cited by 13
Adamska, A., Łebkowska, A., Jacewicz‐Święcka, M., Krentowska, A., Hryniewicka, J., Wołczyński, S., Górska, M., & Kowalska, I. (2017) · International Journal of Endocrinology · doi:10.1155/2017/2316986 · Cited by 14
Insulin resistance in a cohort of 5–15 year old children in urban Sri Lanka
Wickramasinghe, P., Arambepola, C., Bandara, P., Abeysekera, M., Kuruppu, S., Dilshan, P., & Dissanayake, B. S. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2658-x · Cited by 13
Saengkaew, T., Jantarat, C., Nosoognoen, W., & Supornsilchai, V. (2017) · Journal of Pediatric Endocrinology & Metabolism (JPEM) · doi:10.1515/jpem-2017-0172 · Cited by 11
Boghdadi, M. A., Afify, H. E., Sabri, N. A., Makboul, K. M., & Elmazar, M. M. (2017) · Clinical and Experimental Pharmacology · doi:10.4172/2161-1459.1000241 · Cited by 13
The signature of circulating microparticles in heart failure patients with metabolic syndrome
Berezin, A. Е., Kremzer, A. A., Berezina, T. A., et al. (2016) · Journal of Circulating Biomarkers · doi:10.1177/1849454416663659 · Cited by 13
Kang, H. J., Jun, D. W., Lee, S. M., Jang, E. C., & Cho, Y. K. (2018) · Oncotarget · doi:10.18632/oncotarget.23959 · Cited by 13
Risk factors for cardiovascular disease in obese children
Chandrasekhar, T., Suchitra, M. M., Pallavi, M., Rao, P., & Sachan, A. (2017) · Indian Pediatrics · doi:10.1007/s13312-017-1169-0 · Cited by 13
Plasma adrenomedullin level in children with obesity: relationship to left ventricular function
Metwalley, K. A., Farghaly, H. S., & Sherief, T. (2018) · World Journal of Pediatrics · doi:10.1007/s12519-017-0106-6 · Cited by 13
Troponin T3 associates with DNA consensus sequence that overlaps with p53 binding motifs
López, Y. O. N., Messi, M. L., Pratley, R. E., Zhang, T., & Delbono, O. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.03.012 · Cited by 13
Galectin-3 as a novel biomarker in women with PCOS
İlhan, G. A., Kanlioglu, C., Arslan, G., et al. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4862-x · Cited by 13
Ma, Y., Wang, N., Gu, L., Wei, X., Ren, Q., Huang, Q., Zhang, A., Zhang, J., Peng, Y., & Wang, Y. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1512094 · Cited by 13
Dardzińska, J. A., Kaska, Ł., Proczko-Stepaniak, M., et al. (2018) · Videosurgery and Other Miniinvasive Techniques · doi:10.5114/wiitm.2018.75868 · Cited by 13
Ata, N., Maguire, B. R., Hamilton, D. C., & Kuhle, S. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1289-2 · Cited by 13
McDonald, J. D., Mah, E., Dey, P., Olmstead, B. D., Sasaki, G. Y., Villamena, F. A., & Bruno, R. S. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.002 · Cited by 14
Schweinlin, A., Ulbrich, S. E., Stauß, S., Teutsch, M., Walle, H., Basrai, M., & Bischoff, S. (2018) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0668-2891 · Cited by 14
Niederseer, D., Bracher, I., Stadlmayr, A., Huber-Schönauer, U., Plöderl, M., Obeid, S., Schmied, C. M., Hammerl, S., Stickel, F., Lederer, D., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120484 · Cited by 17
Hetherington-Rauth, M., Bea, J., Blew, R., Funk, J., Lee, V., Roe, D., Sardinha, L., & Going, S. (2018) · Bone · doi:10.1016/j.bone.2018.12.013 · Cited by 14
Bhat, P. V., Vinod, V., Alluri, N. P., et al. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.12.010 · Cited by 13
Dahan, M. H., Abbasi, F., & Reaven, G. M. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01014-9 · Cited by 13
Diet Quality Is an Indicator of Disease Risk Factors in Hispanic College Freshmen
Landry, M. J., Asigbee, F. M., Vandyousefi, S., Khazaee, E., Ghaddar, R., Boisseau, J. B., House, B. T., & Davis, J. N. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.12.002 · Cited by 14
Roche, J., Isacco, L., Perret, F., Dumoulin, G., Gillet, V., & Mougin, F. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00309.2018 · Cited by 13
Serum Vitamin D Levels in Fertile and Infertile Women with Polycystic Ovary Syndrome
Kokanalı, D., Karaca, M., Özakşit, G., Elmas, B., & Üstün, Y. E. (2019) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-0828-7798 · Cited by 13
Hypoglycaemic activity of Bauhinia holophylla through GSK3-β inhibition and glycogenesis activation
Camaforte, N. A. D. P., Saldanha, L. L., Vareda, P. M. P., Rezende-Neto, J. M., Senger, M. R., Delgado, A. Q., Morgan, H. J. N., Violato, N. M., Pieroni, L. G., Dokkedal, A. L., et al. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2019.1599962 · Cited by 13
Guedes, M. R., Fittipaldi-Fernandez, R. J., Diestel, C. F., & Klein, M. R. S. T. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03891-8 · Cited by 13
Carreau, A., Jin, E. S., Garcia‐Reyes, Y., Rahat, H., Nadeau, K. J., Malloy, C. R., & Cree‐Green, M. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00047.2019 · Cited by 13
Sridharan, K., Kalayarasan, R., Kamalanathan, S., Sahoo, J., Kar, S. S., Nandhini, L. P., Palui, R., & Durgia, H. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.002 · Cited by 13
Bos, M. M., van Heemst, D., Donga, E., de Mutsert, R., Rosendaal, F. R., Blauw, G. J., Rensen, P. C. N., Biermasz, N. R., & Noordam, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050682 · Cited by 13
Eickhoff, H., Rodrigues, T., Neves, I. J., Marques, D., Ribeiro, D. C., Costa, S., Seiça, R. M. F., & Matafome, P. N. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03935-z · Cited by 14
Mitochondrial mutation m.3243A>G associates with insulin resistance in non-diabetic carriers
Langdahl, J. H., Frederiksen, A. L., Vissing, J., Frost, M., Yderstræde, K. B., & Andersen, P. H. (2019) · Endocrine Connections · doi:10.1530/ec-19-0118 · Cited by 13
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
